Whereas genome-wide association studies (GWAS) allowed identifying thousands of associations between variants and traits, their success rate in pinpointing causal genes has been disproportionately low. Here, we integrate biobank-scale phenotype data from carriers of a rare copy-number variant (CNV), Mendelian randomization and animal modeling to identify causative genes in a GWAS locus for age at menarche (AaM). We show that the dosage of the 16p11.2 BP4-BP5 interval is correlated positively with AaM in the UK and Estonian biobanks and 16p11.2 clinical cohorts, with a directionally consistent trend for pubertal onset in males. These correlations parallel an increase in reproductive tract disorders in both sexes. In support of these observations, 16p11.2 mouse models display perturbed pubertal onset and structurally altered reproductive organs that track with CNV dose. Further, we report a negative correlation between the 16p11.2 dosage and relative hypothalamic volume in both humans and mice, intimating a perturbation in the gonadotropin-releasing hormone (GnRH) axis. Two independent lines of evidence identified candidate causal genes for AaM; Mendelian randomization and agnostic dosage modulation of each 16p11.2 gene in zebrafish gnrh3:egfp models. ASPHD1, expressed predominantly in brain and pituitary gland, emerged as a major phenotype driver; and it is subject to modulation by KCTD13 to exacerbate GnRH neuron phenotype. Together, our data highlight the power of an interdisciplinary approach to elucidate disease etiologies underlying complex traits.
Introduction
Recent studies suggest that, in addition to common variants, rare variants contribute substantially to population variance of complex traits. In particular, individually rare but collectively common copy-number variants (CNVs) have been shown to account for traits such as education attainment, body mass index (BMI) or height [1] [2] [3] [4] . A hallmark example of a rare variant of strong effect on complex traits in humans is the 16p11.2 600 kb BP4-BP5 CNV interval [5] . The deletion (OMIM #611913) and reciprocal duplication (OMIM #614671) of this interval are mediated by positively-selected Homo sapiens-specific low-copy repeats [6, 7] . The 16p11.2 CNVs are among the most frequent known genetic causes of mental disorders such as autism spectrum disorders, schizophrenia and cognitive impairment [5, [8] [9] [10] [11] [12] . They also impact satiety response and BMI in a dosage-dependent manner [13] [14] [15] . Correspondingly, 16p11.2 gene dosage affects head circumference, and specifically, the size of brain structures associated with reward, language and social cognition [9, 13, [15] [16] [17] . Genomewide association studies (GWAS) have identified reproducible associations between common SNPs of the 16p11.2 interval and BMI [18] , schizophrenia [19, 20] and age at menarche (AaM) [21] [22] [23] . However, altered pubertal timing has not been reported as part of the 16p11.2 CNV phenotype, possibly because of ascertainment strategies biased towards pediatric neurodevelopmental cases in CNV studies.
Whereas GWAS have identified thousands of correlations between common genetic variants and complex traits, the success rate in pinpointing the causal genes has been disproportionately low [24, 25] . One recently proposed solution to this challenge involves intersection of expression quantitative trait loci (eQTL) data with GWAS risk loci [26, 27] , a strategy called Mendelian Randomization (MR). This approach aims to resolve gene-trait associations and offer the ability to estimate the strength of the causal effects in GWAS loci [28] [29] [30] .
Here, we coalesce rare CNV associations in unbiased adult populations and clinical cohorts; phenotyping of 16p11.2 mouse models; MR and single gene in vivo zebrafish assays to characterize hitherto unappreciated genetic associations for reproductive traits. Our agnostic approaches identified likely causative genes for impairment of both timing and developmental processes involved in sexual development. 
Materials and methods

Materials and methods are detailed in Supplementary Methods
Study cohorts
16p11.2 mouse models
We assessed female and male reproductive parameters including estrous cyclicity, sperm count, anogenital distance, morphology of urogenital tract organs and hypothalamic volume in previously engineered 16p11.2 Del/+ and 16p11.2 Dup/+ mouse models [31, 32] .
Brain structural magnetic resonance imaging (MRI)
Human structural MRI data were acquired, processed and analyzed as described [16, 17, 33] . The mass-univariate statistical analysis of whole-brain volume maps was performed in 146 postpubertal individuals as described [34] . Mouse MRI was performed as detailed in [35] .
Disease enrichment analysis
We assessed enrichments by g:Profiler [36] and MetaCore TM in lists of genes differentially expressed in 16p11.2 CNV carriers and models [37, 38] .
Mendelian randomization analysis
We used univariate [28] and multivariate [39] [40] [41] MR to assess causal effects of 16p11.2 genes on regulation of AaM.
GnRH neuron phenotyping in zebrafish
We performed overexpression and CRISPR/Cas9 genome editing of 16p11.2 genes in zebrafish embryos as described [42, 43] . In vivo imaging of neuronal patterning in gnrh3:egfp transgenic reporter larvae [44] is described in Supplementary Methods.
Global gene expression similarity
We analyzed expression similarity of identified candidate genes across publicly available human and mouse gene expression datasets using Multi Experiment Matrix (MEM) [45] and funcExplorer [46] tools. Downstream enrichment analyses were conducted using g:Profiler toolset [47] .
Results
Similar to their clinically ascertained counterparts [13] , we demonstrated that adult population biobank carriers of the 16p11.2 CNVs present mirror effects on BMI. We observed that genomic dosage of the 16p11.2 interval is associated significantly with BMI in the first release of the UKBB cohort (first UKBB; ANOVA p=1.65x10 -17 ). We replicated these results in both the independent second release of the UKBB (second UKBB; ANOVA p=5.37x10 -36 ) and the geographically distinct EGCUT (ANOVA p=6.4x10 -08 ) cohorts (Supplementary Results, Table   S2 and Figure S1-S2). Next, we investigated AaM, an understudied trait in 16p11.2 CNV carriers that was associated previously with common SNPs in the 16p11.2 interval [21] [22] [23] . We identified a significant association between 16p11.2 dosage and AaM (corrected ANOVA p=1.93x10 -05 , first UKBB).
Compared to controls (n=60,466; μAAM=12.9 years) AaM was significantly earlier in deletion carriers (n=11; μAAM=11.4 years, Δ=-1.5 years; corrected p=0.00098, Wilcoxon test) and delayed in duplication carriers (n=21; μAAM=14.4 years, Δ=+1.5 years; corrected p=0.002, Wilcoxon test) ( Figure 1A) . These differences were independent of ethnicity ( Supplementary Table S3 and Figure S1-S2) and remained unchanged after correcting for BMI, year of birth, and population structure. We replicated this association in the second UKBB (corrected p=6.5x10 -04 , ANOVA), EGCUT (corrected p=2.4x10 -05 , ANOVA), and confirmed the mirror effect between deletion and duplication in two independent 16p11.2 clinical cohorts (Simons VIP Collection p=7.7x10 -05 ; Pan-European cohort p=0.0034) (Figure 1BC , Supplementary Results and Figure S1 ). We identified a similar, but non-significant trend in males possibly due to a less distinctive onset of puberty in this sex. Compared to controls in the first UKBB, the second UKBB and the Simons VIP cohorts, male deletion carriers trended toward "younger than average age" at the onset of pubertal traits (e.g. all ancestries combined, "first facial hair" in first UKBB: OR=2.73, p=0.08; in second UKBB:
OR=2.69, p=0.025) and duplication carriers, oppositely, toward "older than Table S5 ). We analogously observed that pediatric male duplication carriers in the Simons VIP cohort had an increase in undescended testicles (13.2%, n=5) and hypospadias (5.3%, n=2) compared to published rates [48, 49] . Upon inclusion of other genital problems, 11 out of 38 (29%) boys with 16p11.2 duplication were affected.
Next, we asked if these genetic associations were paralleled by molecular alterations. We analyzed published transcriptome profiles and found that genes correlated with 16p11.2 CNV dosage in lymphoblastoid cell lines (LCLs) derived from 16p11.2 CNV carriers and cerebral cortices of syntenic mouse models [37, 38] were enriched for genes associated with urogenital dysfunctions (LCL: 8 of 25 top-ranked terms, FDR <1.43x10 -06 ; cortex: 9 of 25, FDR <1.75x10 -12 ) (Supplementary Results and Table S6 ). These results prompted us to assess the effect of 16p11.2 dosage on reproductive traits in mouse models. Consistent with previous reports [7, 31] the 16p11.2 Del/+ and 16p11.2 Dup/+ animals showed a mirror effect on body weight that is opposite to that of human 16p11.2 CNV carriers. By recording timing of first ovulation in females, we noted a reciprocal effect on sexual maturation that, similar to weight [31, 32] , was inverted Sexual development in mammals is regulated by hormonal interplay between hypothalamus, pituitary gland and gonads. We used human MRI data [16, 17, 33] to assess possible 16p11.2 dosage-dependent brain anatomy changes. Given our strong a priori hypothesis of an impaired neuroendocrine axis, we restricted the search volume to a 5 mm sphere centered on the hypothalamic region. We found in female CNV carriers, but not in male, a significant negative correlation (pFWE<0.05) between the 16p11.2 CNV dosage and the hypothalamic volume adjusted for individuals' total intracranial volume as proxy for head size (Figure   2F and Supplementary Table S7 ). Consistent with human data, we replicated previously reported abnormal hypothalamic morphology in 16p11.2 Del/+ mouse models [32, 51] . We observed a significant negative correlation between 16p11.2 dosage and hypothalamus volume relative to the total brain volume in female mice. The deletion and duplication animals have, respectively, larger and smaller relative hypothalamic regions than wild type animals (both p<0.0001, one-way ANOVA, post-hoc Tukey; Figure 2G and Supplementary Table S8 ). These results suggest that volumetric perturbations of the hypothalamus, a structure comprised of GnRH secreting neurons essential for initiating puberty and activating the hypothalamus-pituitary-gonadal axis, could contribute to the 16p11.2-linked alterations of sexual development.
To determine which genes in the 16p11.2 interval ( Figure 3A) are causally relevant for AaM, we performed two-sample uni- [28] and multivariate [39, 40] MR using GWAS summary statistics for AaM [22] and an eQTL meta-analysis of 14,115 whole-blood samples [52] . We obtained support for causality for four genes, two of which were identified by both analyses, INO80E (uni: b=0.098, SE=0.015, p=1.3x10 -10 ; multi: b=0.071, SE=0.018, p=9.3x10 -5 ) and KCTD13 (uni: b=-0.154, SE=0.034, p=4.5x10 -6 ; multi: b=-0.074, SE=0.023, p=9.7x10 -4 ) ( Figure   3BC ; Supplementary Table S9 and Figure S3 ). However, less than half (12 out of 28) of the unique 16p11.2 interval genes could be tested, while the rest had insufficient valid instruments. Independently, we modulated the dosage of all 16p11.2 genes agnostically in a Tg(gnrh3:egfp) transgenic zebrafish model (Supplementary Figure S4) [44, 53] and monitored GnRH3 neuron patterning in vivo using an automated imaging platform [54, 55] . The processes governing GnRH axis establishment in zebrafish are highly conserved with mammals.
Importantly, gnrh3 neurons in zebrafish perform hypophysiotropic roles in control of neurogenesis, neuronal migration and reproduction [56] . To model the 16p11.2 duplication, we evaluated the consequences of overexpressing each human mRNA on relative GnRH3 reporter neuron area in the dorsal aspect (n=6,700 larvae; Figure 4A ). We measured the area of GFP (green fluorescent protein)-positive cells at 5 days post fertilization (dpf) and found that overexpression of only a single transcript, ASPHD1 (that was not testable by MR), was sufficient to reduce GFP signal significantly in comparison with controls (19% reduction; p<0.0001, one-way ANOVA, post-hoc Tukey) (Figure 4BC ;
Supplementary Results and Table S10). To model ASPHD1 hemizygosity, we depleted endogenous asphd1 zebrafish transcripts by CRISPR/Cas9 genome editing and quantified the gnrh3:egfp neuron area of F0 (founder) mutant larval batches at 5 dpf. We found that reduced expression of asphd1 also triggered a significant decrease of GFP signal in F0 versus controls (13% reduction, p=0.0031, one-way ANOVA, post-hoc Tukey; Figure 4BD ; Supplementary Results and Table S10). We have shown previously that genes within the 16p11.2 interval can interact to induce additive or epistatic phenotypes [35, 42, 43, 57] . To investigate whether other genes in the 16p11.2 region could also exacerbate or mitigate the ASPHD1 effect on the developing reproductive axis, we halved the dose of ASPHD1 and co-injected KCTD13, INO80E, MAPK3 or YPEL3, the genes that showed causal evidence in MR. We found that the larvae co-injected with ASPHD1 and KCTD13 showed a significantly aggravated phenotype (compared to controls: 24% reduction, p<0.0001; compared to ASPHD1 mono-injected batches: 14% reduction, p=0.003, one-way ANOVA, posthoc Tukey) suggesting genetic interaction between these two genes (Figure 4E ; Table S11 ).
Supplementary Results and
ASPHD1 encodes aspartate beta-hydroxylase domain containing 1, a protein of relatively unknown function. We used global gene expression similarity analysis in human and mouse to gain insight into its biological role. We found that ASPHD1 is co-expressed with genes related to synaptic vesicle function, in particular, with SEZ6L2, its distal physical neighbor on 16p11.2; and with CELF4 a transcript encompassing SNPs associated with neuroticism and depression [58] (Figure S5 ; the results are available at http://bit.ly/asphd1hsapiens and http://bit.ly/asphd1mmusculus). The three genes share specific expression patterns in multiple brain regions and pituitary (GTEx data set of 38 human tissues), with ASPHD1 and CELF4 belonging to the same cluster of 258 coregulated genes enriched for neuronal processes ("neuron projection" GO:0043005, p=2.16x10 -09 ; "transmission across chemical synapses" REAC:112315, p=1.04x10 -10 ; "neurotransmitter receptor binding and downstream transmission in the postsynaptic cell" REAC:112314, p=3.7x10 -09 ) ( Figure 3D and Figure S6 ; g:profiler results are available at https://biit.cs.ut.ee/gplink/l/AOYgmspNQu).
Discussion
Accumulating evidence suggests that common and rare variation act additively to influence complex traits [59, 60] . Here, we report a model to leverage information from both rare and common variants to understand the biological basis of reproduction, a multifactorial phenotype.
Despite numerous studies on the 16p11.2 CNVs in clinical cohorts, involvement in the reproductive axis was mostly overlooked with the exception of a reported enrichment of 16p11.2 BP4-BP5 deletions in Müllerian aplasia patients [61, 62] .
Here, we show that the 16p11.2 dosage in humans and mice is associated significantly with pubertal onset, reproductive traits and hypothalamus volume.
Thus, we add to the repertoire of previously reported links between these CNVs and mental disorders, BMI, head circumference and brain size [8, 9, 12, 13, 15, 16, 31, 32] . The hitherto underappreciation of sexual development phenotypes may have resulted from an ascertainment bias, wherein phenotypes presenting with early onset and the greatest medical management challenges were prioritized. Notably, our findings are consistent with a convergent theme of endocrine, metabolic and behavioral phenotypes in rare CNV carriers and common variant associations in the 16p11.2 locus [18, 22, 63] .
Akin to GWAS loci, CNVs present a defined interval associated to phenotype, but often offer no distinct causative genes [64] . Whereas MR has become a popular tool for post-GWAS prioritization of causally relevant genes, authors of these initial studies have refrained from functional validation of their findings de facto acknowledging that insufficient eQTL data from the target tissues might be an insurmountable limitation [28, 30] . Here, we exploited the benefits of large-scale MR and overcame its tissue-specific limitation by agnostically assessing the effect of single gene dosage alteration on patterning of GnRH-expressing neurons in the context of zebrafish development. We demonstrate the power of combining in silico and in vivo methods by identifying ASPHD1 and KCTD13 as the driver and modifier of the 16p11.2 reproductive axis, respectively.
KCTD13 was shown previously to act on neurogenesis through RhoA signaling; reduced KCTD13 levels result in concomitantly reduced synaptic transmission [42, 65] . Although the function of ASPHD1 is unknown, its expression is restricted to the brain and pituitary gland (https://gtexportal.org) lending support to the above-cited tissue-specific shortcomings of in silico causality predictions. Further, the spatially constrained expression pattern of ASPHD1 (Figure 3D ) strengthens the tentative link to the neuroendocrine axis that governs pubertal timing. We show that ASPHD1 is co-expressed with genes involved in neurotransmission and synaptic vesicle location and function. In particular, CELF4 is involved in neurodevelopmental regulation [66] and is associated with educational attainment [67] , neuroticism and mood related alterations [68] [69] [70] . Notably, the potential contribution of ASPHD1 to reproductive function via a putative role in synaptic vesicle integrity is consistent with the biological roles of some Mendelian GnRH deficiency disorder genes. For example, recessive mutations in DMXL2, encoding the synaptic vesicle protein rabconnectin-3α, cause delayed puberty due to a reduction of GnRH neurons in the hypothalamus and attenuated kisspeptin responsiveness [71, 72] .
Further studies will be required to elucidate the molecular roles and interaction partners of ASPHD1.
Two other genes residing at 16p11.2, TBX6 and MAZ, were associated previously with congenital defects of kidney and urinary tract [73, 74] , while GWAS have suggested TBX6 [23] , MAPK3 [21] and INO80E [22] as potential candidates for AaM. Furthermore, the 14-gene cluster (distal to proximal: SPN, QPRT, ZG16, KIF22, PRRT2, MAZ, MVP, SEZ6L2, ASPHD1, KCTD13, TMEM219, TAOK2, INO80E, DOC2A) was shown to be under coordinated estrogen-mediated regulation [75] .
Together, these data offer independent support of the genetic complexity underlying phenotypes in the 16p11.2 locus and reinforce a likely oligogenic etiology with primary drivers and multiple modifiers governing the variance in associated traits [42, 57, 76, 77] .
In conclusion, our study illustrates how characterization of traits associated with rare variants in unselected adult populations can provide unbiased insight into disease etiology. We demonstrate further the power of an interdisciplinary approach to pinpoint candidate genes and underlying biological processes in GWAS loci for complex traits. 
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